Business / Biotech and Pharma

Novartis to Acquire Avidity Biosciences for $12 Billion

Novartis has announced its plan to acquire Avidity Biosciences for $12 billion in cash, marking a significant move to bolster its neuroscience pipeline and RNA therapeutics capabilities. The deal is expected to close in the first half of 20...